Brief: Arbutus Reports Fourth Quarter And Year End 2022 Financial Results And Corporate Update
Arbutus Biopharma Corp ABUS.O :
* ARBUTUS REPORTS FOURTH QUARTER AND YEAR END 2022 FINANCIAL
RESULTS AND CORPORATE UPDATE
* ARBUTUS BIOPHARMA CORP SEES CASH RUNWAY INTO Q4 2024
Source text for Eikon: ID:nGNX5g7Pfk
Further company coverage: ABUS.O
Recent news on Arbutus Biopharma
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Arbutus rises after FDA lifts clinical hold for experimental hepatitis B drug
Brief: Arbutus Announces Final Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
Brief: Arbutus Announces Preliminary Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare